Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies

Colorectal cancer (CRC) biopsies underpin accurate diagnosis, but are also relevant for patient stratification in molecularly-guided clinical trials. The consensus molecular subtypes (CMSs) and colorectal cancer intrinsic subtypes (CRISs) transcriptional signatures have potential clinical utility fo...

Full description

Bibliographic Details
Main Authors:	Alderdice, M, Richman, S, Gollins, S, Stewart, J, Hurt, C, Adams, R, McCorry, A, Roddy, A, Vimalachandran, D, Isella, C, Medico, E, Maughan, T, McArt, D, Lawler, M, Dunne, P
Format:	Journal article
Language:	English
Published:	Wiley 2018

Similar Items

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
by: Dunne, P, et al.
Published: (2017)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
by: Lafarge, MW, et al.
Published: (2024)

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.
by: Jain, S, et al.
Published: (2017)

Standardising RNA profiling based biomarker application in cancer—The need for robust control of technical variables
by: Stewart, J, et al.
Published: (2017)

Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer - Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
by: Middleton, G, et al.
Published: (2011)

Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning
by: Sirinukunwattana, K, et al.
Published: (2020)

Fine needle aspiration biopsy, core needle biopsy or excision biopsy to diagnose breast cancer - which is the ideal method?
by: Tham, T., et al.
Published: (2009)

Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
by: Seymour, M, et al.
Published: (2011)

Accurate subtyping of lung cancers by modelling class dependencies
by: Batchkala, G, et al.
Published: (2024)

New techniques for sentinel node biopsy in breast cancer
by: Ferrucci, M, et al.
Published: (2018)

Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
by: Mavaddat, N, et al.
Published: (2018)

Genetic alterations in the molecular subtypes of bladder cancer: Illustration in the Cancer Genome Atlas dataset
by: Choi, W, et al.
Published: (2017)

Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification
by: Kleeman, S, et al.
Published: (2019)

Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
by: Yang, L, et al.
Published: (2018)

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
by: Berridge, C, et al.
Published: (2024)

Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium
by: Ose, J, et al.
Published: (2017)

Automated breast density measurement in mammography for cancer risk stratification
by: Deen, S
Published: (2021)

Comparison of multiparametric magnetic resonance imaging and targeted biopsy with systematic biopsy alone for the diagnosis of prostate cancer: A systematic review and meta-analysis
by: Elwenspoek, M, et al.
Published: (2019)

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer
by: Malla, SB, et al.
Published: (2024)

Cancer Metabolic Subtypes and Their Association with Molecular and Clinical Features
by: Moiso, Enrico, et al.
Published: (2022)

Cancer Metabolic Subtypes and Their Association with Molecular and Clinical Features
by: Moiso, Enrico, et al.
Published: (2022)

Towards the identification of histology based subtypes in prostate cancer
by: Chatrian, A, et al.
Published: (2019)

Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study
by: Bryant, R, et al.
Published: (2018)

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
by: Ankerst, D, et al.
Published: (2014)

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
by: Mouradov, D, et al.
Published: (2014)

Is sentinel node biopsy necessary in the radiologically negative axilla in breast cancer?
by: Jozsa, F, et al.
Published: (2019)

Personalised cancer follow-up: risk stratification, needs assessment or both?
by: Watson, E, et al.
Published: (2012)

Dietary fat intake and development of specific breast cancer subtypes.
by: Sieri, S, et al.
Published: (2014)

Adiposity and risk of oesophageal cancer subtypes in the Million Women Study
by: Sweetland, S, et al.
Published: (2023)

Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium
by: Wentzensen, N, et al.
Published: (2016)

Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
by: Cheng, Li-Jen, et al.
Published: (2022)

Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands.
by: Maruta, F, et al.
Published: (2007)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
by: Freedman, J, et al.
Published: (2017)

Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.
by: Haas, G, et al.
Published: (2007)

KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
by: West, N, et al.
Published: (2012)

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
by: Crosby, T, et al.
Published: (2013)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
by: Crosby, T, et al.
Published: (2017)

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
by: Gollins, S, et al.
Published: (2019)

Multimodal spectroscopy : real-time diagnosis of breast cancer during core needle biopsy
by: Volynskaya, Zoya I
Published: (2011)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.
by: Macefield, R, et al.
Published: (2010)